Idiopathic Orthostatic Hypotension and other Autonomic Failure Syndromes Follow-up
- Author: Mohini Gurme, MD; Chief Editor: Selim R Benbadis, MD more...
Further Inpatient Care
See the list below:
- Physical therapy is useful for gait training. Patients also should be instructed in safety precautions.
- Patients should be monitored closely for drug efficacy and adverse effects. Doses should be adjusted accordingly.
See the list below:
- The prognosis for autoimmune autonomic neuropathy (AAN) is poor without treatment, and many patients have residual autonomic symptoms. With IVIg therapy, a few patients who are treated early in the disease course can have excellent recovery of function. However, additional patients must be treated to confirm the initial favorable findings.
- Patients with pure autonomic failure have symptoms that remain confined to the autonomic nervous system. These patients generally improve little over time, and their symptoms may worsen. Some may later develop multiple system atrophy or Parkinson's disease.
- The prognosis for patients with multiple system atrophy is poor overall. Neurologic function declines gradually over time. The autonomic symptoms often become debilitating. Survival is typically 6-9 years from the time of diagnosis.
Brooks M. FDA Clears Droxidopa for Neurogenic Orthostatic Hypotension. Medscape Medical News. Available at http://www.medscape.com/viewarticle/820786. Accessed: February 24, 2014.
Klein CM, Vernino S, Lennon VA, et al. The spectrum of autoimmune autonomic neuropathies. Ann Neurol. 2003. 53:752-8. [Medline].
Sandroni P, Vernino S, Klein CM, et al. Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. Arch Neurol. 2004 Jan. 61(1):44-8. [Medline].
Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999 Feb 1. 163(1):94-8. [Medline].
Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med. 2008 Feb 7. 358(6):615-24. [Medline].
Yu X, Stavrakis S, Hill MA, Huang S, Reim S, Li H, et al. Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension. J Am Soc Hypertens. 2012 Jan-Feb. 6(1):40-7. [Medline]. [Full Text].
Barclay L. Low B12 Linked to Orthostatic Tachycardia in Adolescents. Medscape Medical News. Dec 23 2013. Available at http://www.medscape.com/viewarticle/818279. Accessed: Jan 7 2014.
Oner T, Guven B, Tavli V, Mese T, Yilmazer MM, Demirpence S. Postural Orthostatic Tachycardia Syndrome (POTS) and Vitamin B12 Deficiency in Adolescents. Pediatrics. 2014 Jan. 133(1):e138-42. [Medline].
Sithinamsuwan P, Orrawanhanothai P, Thithum K, Udommongkol C, Chairangsaris P, Chinvarun Y, et al. Orthostatic hypotension: a non-motor complication assessment in 82 patients with idiopathic Parkinson's disease in Phramongkutklao Hospital. J Med Assoc Thai. 2010 Nov. 93 Suppl 6:S93-9. [Medline].
Sommer C, Lauria G. Skin biopsy in the management of peripheral neuropathy. Lancet Neurol. 2007 Jul. 6(7):632-42. [Medline].
Schroeder C, Vernino S, Birkenfeld AL, et al. Plasma exchange for primary autoimmune autonomic failure. N Engl J Med. 2005 Oct 13. 353(15):1585-90. [Medline].
Heafield MT, Gammage MD, Nightingale S, Williams AC. Idiopathic dysautonomia treated with intravenous gammaglobulin. Lancet. 1996 Jan 6. 347(8993):28-9. [Medline].
Quan D, Rich MM, Bird SJ. Acute idiopathic dysautonomia: electrophysiology and response to intravenous immunoglobulin. Neurology. 2000 Feb 8. 54(3):770-1. [Medline].
Gibbons C, Vernino S, Freeman R. Combined immunomodulation therapy in autoimmune autonomic ganglionopathy. Arch Neurol. Feb 2008. 65(2):213-217.
Bannister R, Mathias CJ, Polinsky R. Autonomic failure--A comparison between UK and US experience. Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System. New York, NY: Oxford University Press; 1988. 282-8.
Daniel SE. The neuropharmacology and neurochemistry of multiple system atrophy. Autonomic Failure: A Textbook of Disorders of the Autonomic Nervous System. New York, NY: Oxford University Press; 1992. 564-85.
Hoeldtke RD, Bryner KD, Hoeldtke ME, Hobbs G. Treatment of autonomic neuropathy, postural tachycardia and orthostatic syncope with octreotide LAR. Clin Auton Res. 2007 Dec. 17(6):334-40. [Medline].
Kaufmann H. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res. 1996 Apr. 6(2):125-6. [Medline].
Mathias CJ. Disorders of the autonomic nervous system. Neurology in Clinical Practice. Boston, Mass: Butterworth-Heinemann; 1996. 1953-81.
Matthews MR. Autonomic ganglia in multiple system atrophy and pure autonomic failure. Autonomic Failure: A Textbook of Disorders of the Autonomic Nervous System. New York, NY: Oxford University Press; 1992. 593-621.
Quinn NP, Wenning G, Marsden CD. The Shy-Drager syndrome. What did Shy and Drager really describe?. Arch Neurol. 1995 Jul. 52(7):656-7. [Medline].
Smit AA, Vermeulen M, Koelman JH, Wieling W. Unusual recovery from acute panautonomic neuropathy after immunoglobulin therapy. Mayo Clin Proc. 1997 Apr. 72(4):333-5. [Medline].
Suarez GA, Fealey RD, Camilleri M, Low PA. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology. 1994 Sep. 44(9):1675-82. [Medline].
van Ingelghem E, van Zandijcke M, Lammens M. Pure autonomic failure: a new case with clinical, biochemical, and necropsy data. J Neurol Neurosurg Psychiatry. 1994 Jun. 57(6):745-7. [Medline].
Vernino S, Freeman R. Peripheral Autonomic Neuropathies. Continuum Lifelong Learning Neurol. 2007 Dec. 13(6):89-110.